Citation Impact
Citing Papers
Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma
2009
Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
2011 StandoutNobel
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Interaction of Hydroxylated Collagen IV with the von Hippel-Lindau Tumor Suppressor
2007 StandoutNobel
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
2015 StandoutNobel
Cancer is a Preventable Disease that Requires Major Lifestyle Changes
2008 Standout
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile
2008
Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations
2007 StandoutNobel
Anti-cancer natural products isolated from chinese medicinal herbs
2011 Standout
The effects of oxidative stress on female reproduction: a review
2012 Standout
Obstructive nephropathy: towards biomarker discovery and gene therapy
2006
High‐resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma
2007
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
The third dimension bridges the gap between cell culture and live tissue
2007 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
2005
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
The von Hippel–Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis
2004
Angiogenetic Signaling through Hypoxia
2005
New Insights into the Biology of Renal Cell Carcinoma
2011 StandoutNobel
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
2012 StandoutNatureNobel
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
2009 Standout
HIF-1 Inhibits Mitochondrial Biogenesis and Cellular Respiration in VHL-Deficient Renal Cell Carcinoma by Repression of C-MYC Activity
2007 StandoutNobel
The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor α
2004 StandoutNobel
Vascular Matrix Metalloproteinase-9 Mediates the Inhibition of Myogenic Reactivity in Small Arteries Isolated from Rats after Short-Term Administration of Relaxin
2006 Standout
Understanding the Importance of Smart Drugs in Renal Cell Carcinoma
2006
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness
2005
Infections in the male genital tract and reactive oxygen species
1999
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway
2005 Standout
Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
2003 StandoutNobel
Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
2014
Renal-Cell Carcinoma
2005
Pathogenesis of renal injury in obstructive uropathy
2006
An Updated Systematic Review of the Pharmacology of Silymarin
2007
Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis
2011
How were new medicines discovered?
2011 Standout
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma
2010
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
Milk thistle in liver diseases: past, present, future
2010 Standout
Role of reactive oxygen species in the pathophysiology of human reproduction
2003 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Multitargeted therapy of cancer by silymarin
2008 Standout
Upregulation of prostate‐derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells
2011
Targeting silibinin in the antiproliferative pathway
2010
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer
2013
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
2010 StandoutNobel
Combined classical cytogenetics and microarray‐based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma
2010
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
2013
Mitochondrial disorders in renal tumors
2006
Fibroblasts in cancer
2006 Standout
Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth
2003
Renal cell carcinoma
2017 Standout
HIF-1 mediates the Warburg effect in clear cell renal carcinoma
2007 StandoutNobel
Prostate cancer invasion and metastasis: insights from mining genomic data
2013
Testicular Pathology in 46,XY Dysgenetic Male Pseudohermaphroditism: An Approach to Pathogenesis of Testis Cancer
2001
Natural Polyphenols for Prevention and Treatment of Cancer
2016 Standout
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
2017 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Biology and Clinical Development of Vascular Endothelial Growth Factor–Targeted Therapy in Renal Cell Carcinoma
2004
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Urolithiasis in children.
2005
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Chemopreventive Efficacy of Silymarin in Skin and Prostate Cancer
2007
Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel‐Lindau gene status
2006
Anticancer potential of silymarin: from bench to bed side.
2007
Flavonoids in Cancer and Apoptosis
2018 Standout
The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model
2004
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
The Role of Nutraceuticals in Chemoprevention and Chemotherapy and Their Clinical Outcomes
2011
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of Rolf-Hermann Ringert being referenced
Characterization of an Animal Model of Spontaneous Congenital Unilateral Obstructive Uropathy by cDNA Microarray Analysis
2003
Difference in DNA index of seminomas and nonseminomas
2009
Evaluation of seminal plasma parameters in patients with chronic prostatitis or leukocytospermia
2009
Losses of 1p and chromosome 14 in renal oncocytomas
2005
Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas
2001
Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer
2005
Extrakorporale Stoßwellenlithotripsie eines Nierenbeckenausgußsteines bei einem 15 Monate alten Säugling
1990
Differential expression of the heat shock protein 70 in the histological compartments of nephroblastomas.
2001
The relevance of estrogen receptor-β expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment
2007
IMPAIRED NEPHROGENESIS IN RATS WITH CONGENITAL OBSTRUCTIVE UROPATHY
2001
Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis.
2001
Inhibition of Telomerase Activity and Secretion of Prostate Specific Antigen by Silibinin in Prostate Cancer Cells
2004
cDNA microarray analysis with amplified RNA after isolation of intact cellular RNA from neoplastic and non-neoplastic prostate tissue separated by laser microdissections
2004
Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors.
2003